1. Generics Bulletin

Who’s Hired? Ananth Returns To Teva As New API Chief

As Strides Switches COO And Civica Rx Announces Sterile Injectables Site Manager

 
• By Dave Wallace

Teva has announced that R. Ananthanarayanan – known as Ananth – is to rejoin the company as CEO of its active pharmaceutical ingredients business after taking leading roles at Cipla and Strides in recent years. Meanwhile, Strides has disclosed a change of chief operating officer coming next year, while Civica Rx has named a manager for its sterile injectables operations.

Welcome back spelled out in tiles
R. Ananthanarayanan is returning to Teva • Source: Shutterstock

Teva has announced that its former active pharmaceutical ingredient and biologics operations chief of several years ago, R. Ananthanarayanan, is to rejoin the company as CEO of its Teva API business from 27 November. He will be based out of Teva’s US headquarters in Parsippany, New Jersey.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Leadership

More from Generics Bulletin